Additional European Equity News

AstraZeneca (AZN LN) - Koselugo recommended for EU approval. In other news, Tezspire is recommended for approval in the EU for CRSwNP. (Newswires)

Canal+ (CAN LN) - Co. acquires a majority stake in Multichoice. (Newswires) 

Fugro (FUR NA) - Withdraws FY guidance. Still expect H2 to show a "notable improvement" vs H1, the prev. guided 20% revenue growth is "no longer realistic". "A wide range of projects has been affected – with most experiencing postponements into 2026 and some being descoped – resulting in an estimated revenue impact of around EUR 100mln". (Fugro) Seen opening -5% to -10%

Adecco (ADEN SW) upgraded to Outperform from Market Perform at Bernstein 

ASML (ASML NA) upgraded to Overweight from Equal Weight; PT raised to EUR 950 (prev. EUR 600)